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efit from coronary revascularization prior to vascular surgery (VAS). We have
shown that pts with 1 or 2 preop clinical markers (DM, prior MI, 0 wave
on ECG (OWAVE). angina, age> 70 yrs, CHF) are at intermediate risk for
postop and late cardiac events and should be considered for non-invasive
stress testing to identify those who may benefit from selected preop coro-
nary angiography(ANGIO) and revascularization. To determine if certain high
risk subgroups of elderly pts could be identified based on simple clinical
features and to compare clinical stratification in elderly vs young pts, we re-
viewed the results of consecutive ANGlO of 263 elderly pts (~70 years) and
265 young pts «60 years) presenting to the Cleveland Clinic Foundation for
VAS who had ANGlO::: 6 months prior to VAS. Severe stenoses (ANG(+))was
defined: triple vessel (~50% stenosis in each), 2 vessel (~50% stenosis in
one when the other is ~70% LAD), or left main ~50%; others were called
ANG(-). Results: With increasing number of clinical markers, a gradient of
risk for ANG( +) was seen in the elderly (17%,55%,85%, P < 0.00001) and
the young (14%, 36%,68%, P < 0.00001). for 0,1-2, and ~3 markers, respec-
tively. Relative Risk (95% Confidence Intervals) for independent predictors of
ANG (+) were: Elderly: Angina 9 (4,10). DM 4(2, 8), and OWAVE 3 (2, 6).
Young: Angina 5 (2,10), and OWAVE 6 (3,14).
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1709-41 Intraaortic Balloon Pump Counterpulsation in
Octogenarians: Outcome and Complications
Roger J. Laham, Joseph P. Carrozza, Richard E. Kuntz, Donald S. Baim, Julian
M. Aroesty, David J. Cohen. Harvard Medical School, Beth Israel Hospital, Boston, MA
The use of intraaortic balloon pump counterpulsation (IABP) in octogenari-
ans has not been well defined. Pts 80 years of age or older, who underwent
percutaneous insertion of IABP at the Beth Israel Hospital between 1987 and
1994, inclusively, were identified. 48 Pts had 49 IABP and are the focus of
this report. The mean age was 83 ± 3 (range 80-90) years and 41 % were
women. 6 Pts had diabetes mellitus and 6 Pts had hypertension. The indi-
cation for counterpulsation was acute myocardial infarction in 42 Pts (87%)
with cardiogenic shock in 11 Pt (23%) and refractory angina in 6 Pts (12%).
Mean PCWP was 21 ± 11 mmHg and mean cardiac index was 2.5 ± 0.7
Umin/m2 Baseline creatinine was 1.4 ± 0.6 mg/dl. Peak CK-MB in Pts with
myocardial infarctions was 112 ± 128 Lu. Mean catheter size was 9.7 ±
0.6 French and 9 insertions (18%) were sheathless. 14 Pts (29%) underwent
percutaneous revascularization and 28 Pts (55%) had coronary artery bypass
surgery ± valve replacement. The mean diastolic augmentation was 51 ± 31
mmHg and the mean systolic unloading was 22 ± 18 mmHg. The average
hospital stay was 16 ± 12 days. Strokes were seen in 3 Pts (6%). 9 Pt (19%)
had vascular complications requiring surgical repair. Pts with smaller body
surface area had a higher vascular complication rate ip = 0.04). There were
19 (40%) in-hospital deaths and 4 deaths on follow-up. None of the deaths
were related to IABP. The average duration of follow-up was 14 ± 21 months.
The 30 day mortality was 40% and the one year mortality was 47%. A history
of hypertension and the presence of cardiogenic shock were found to be in-
dependent predictors of poor survival ip = 0.004, P < 0.001, respectively).
Conclusion: While IABP effectively augments diastolic BP and unloads the
left ventricle in octogenarians, its use is associated with a high mortality rate
which may reflect the poor prognosis of myocardial infarction and shock in
this population. Vascular complications are higher than historically reported
in younger patients and are inversely related to body surface area.
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Peripheral Angioplasty in the Elderly: Safe and
Beneficial
Conclusions: The elderly have an extremely high prevalence of severe CAD
with angina and DM alone correlating with a high risk of severe anatomy. To
approach this risk associated with a single marker in the elderly, young pts
need ~3 clinical markers.
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Because intravascular ultrasound (IVUS) enables quantitative analysis of ves-
sel size, plaque burden, and luminal dimensions, it is uniquely suited to deter-
mine the in vivo mechanisms of acute gain following coronary intervention.
The purpose of this study was to compare the mechanisms of acute lumi-
nal enlargement in a patient population randomized to PTCA or stent.
Between 11/93 and 7/94, 23 patients (PTCA = 11, Stent = 12) underwent
prospective pre-intervention (Pre) and post-procedure (Post) IVUS imaging
using a 2.9 Fr. 30 MHz monorail catheter (CVIS). Pre and Post minimal lumen
area (MLA), minimal external elastic lamina area (EELA), and plaque&media
area (P&MA) were determined. There was no significant statistical differ-
ence in these values pre-intervention. Acute gain (~MLA), vessel expansion
(~EELA) and plaque compression (~P&MA) were then calculated. All calcu-
lated areas are in mm2 and are summarized below:
Mechanisms of Acute Luminal Enlargement in
PTCA and Stent: A Prospective Intravascular
Ultrasound Study
1902-11
Raffi K. Krikorian, Paul H. Kramer, James L. Vacek. Mid America Heart Institute and
Saint Luke's Hospital, Kansas City. MO
The outcome of percutaneous transluminal angioplasty (PTA) of lower ex-
tremity peripheral arterial disease (PAD) in the elderly is not well docu-
mented. Between June 1988 and June 1994, 206 patients (pts) had PTA
for symptomatic PAD. Cohorts of patients greater than 70 years (78 pts,
105 PTA's, mean age 76 years). and less than 70 years (128 pts, 188 PTA's,
mean age 60 years, P < 0.0001) were analyzed. The younger patients were
more frequently males (75% vs 52%, P < 0.0001). smokers (45% vs 23%,
P < 0.0001), with higher prevalence of coronary disease (76% vs 60%, P <
0.006). and hyperlipidemia (70% vs 51 %, P < 0.02). The prevalence of di-
abetes and hypertension was similar. Patients above 70 years of age (398
lesions). and patients less than 70 years of age (509 lesions) had different
lesion distribution. Older patients tended to have more diffuse and distal
disease (P < 0.0001). However, the success rate of PTA was similar in both
groups (96 vs 97% for all lesions, P = NS). and 84 vs 89% for total chronic
occlusions (P = NS) in younger versus older patients.
Complication rates did not differ significantly between groups. There were
no strokes, infarctions, amputations, emergent bypasses, or deaths in either
group. A mean follow-up of 29 ± 20 months, the symptomatic improvement
was 77% versus 62% in younger versus older patients «055 NS). There
was no significant difference in the rate of revascularization by PTA or bypass
surgery in both groups.
Conclusions: 1) Elderly patients with PAD have more underlying risk fac-
tors and more extensive and distal disease than younger patients. In spite
of this, procedural success and complication rates are similar for the two
age groups. 2) Symptomatic improvement after PTA can be maintained for
extended periods of time in the elderly patients.
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Preoperative Risk Stratification for Geriatric Patients
Approaching Vascular Surgery: High Prevalence of
Severe Coronary Artery Disease (CAD) Among
Patients with Angina or Diabetes Mellitus
Sumita D. Paul, Norman R. Hertzer, Jess R. Young, Kim A. Eagle. Cleveland Clinic
Foundation, Cleveland, OH; Mass General Hospital, Boston, MA
Preop evaluation of geriatric pts may identify those at risk for perioperative
and long-term cardiac events and a small fraction who could potentially ben-
PTCAln = 11) Stent In = 12) p·value
Acute Gain 4.0 ± 0.63 666 ± 0.36 0001
I~MLA)
Plaque Compression 3.29 ± 073 3.82 ± 0.70 NS
I~P&MA)
Vessel Expansion 0.76 ± 049 2.65 ± 0.68 0.036
(MELA)
Conclusions: 1) Intracoronary stenting is associated with a significantly
larger acute luminal gain. 2) This acute gain is due to a greater increase in EEL
dimensions in the stent group and is suggestive of greater vessel expansion,
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Intravascular Ultrasound Analysis of Routine High
Pressure Balloon Post·Dilatation After
Palmaz-Schatz Stent Deployment
Ronald P. Caputo, John J. Lopez, Kalon K.L. Ho, George Y. Paik, Richard E. Kuntz,
Donald S. Baim, Joseph P. Carrozza. Harvard Medical School, Beth Israel Hospital,
Boston, MA
In an effort to maximize the acute gain in luminal dimensions following stent
deployment, high pressure (12-16 bar) inflations within the stented seg-
ments were performed using a non compliant balloon. Stents were deployed
at pressures just enough to completely expand the highly compliant stent
balloon (4-6 bar). Using intravascular ultrasound (IVUS) luminal diameters in
major and minor axis and luminal cross sectional area (CSA) at the narrow-
est segment within the stent were assessed before and after high pressure
balloon inflationls) (30 MHz; CVIS). The results in 16 patients receiving 19
stents for acute or threatened closure complicating PTCA are shown below
(Mean ± S.D) Ouantatitive angiographic analysis for each stent size group
was performed using electronic digital calipers.
1902-41
To examine the effect of routine high pressure post-dilation (HPD) following
Palmaz-Schatz stent deployment, intravascular ultrasound (IVUS) was used
to measure stent expansion and luminal cross sectional area (LCSA) in 25 le-
sions (7 native vessels and 18 saphenous vein grafts). Following deployment,
each stent was dilated to 14 atm with a non-compliant balloon regardless of
angiographic appearance. OCA revealed a mean balloon size of 3.56 ± 0,52
mm, a balloon to artery ratio of 1.2, and a residual angiographic stenosis of
-12.4%. IVUS was then performed within, as well as 5 mm proximal and
distal to the stent. In a subset of 8 stents 132%), IVUS was also periormed
before HPD. Measurements within the stent were compared to reference
vessels 5 mm proximal and distal to the stent margins, HPD increased stent
MLD from 2.9 to 3.5 mm (p = 0.03), and LCSA from 8.9 to 11.6 mm2 (p =
0.01), LCSA was ~ distal reference LCSA in 68%, ~ proximal reference LCSA
in 57%, and ~60% of the average of proximal and distal reference vessel ex-
ternal elastic lamina areas (ECSA) in 96% of stents respectively. Minimum
lumen diameter (MLD) was ~ distal reference MLD and ~ proximal refer-
ence MLD following HPD in 60% and 43% of stents respectively. By IVUS,
struts appeared fully apposed to the arterial wall in 72% of stents, and the
incidence of intraluminal dissection was only 2.4% following HPD.
potential risk for angiographic complications using these aggressive balloon
strategies must be periormed.
Conclusions 1) HPD can be safely performed following stent placement
and significantly increases LCSA and MLD. 2) It depends on which specific
angiographic or IVUS criteria are used to define "optimal stenting", whether
routine post dilatation of Palmaz-Schatz stents with a non-compliant balloon
to 14 atm is or is not effective in achieving these goals.
Do High Pressure Balloon Inflations Improve
Acute Gain within Flexible Metallic Coil Stents? An
Intravascular Ultrasound Assessment
Suresh P. Jain, Ming W. Liu, Sriram S. Iyer, J. Michael Parks, Ramesh B. Babu,
Sanjay Yadav, Larry S. Dean, William A. Baxley, Navin C. Nanda, Gary S. Roubin.
Unwer~~ofALatBifmmgham,Bifmmgham,AL
Stent Size Inflation Pressure Minor Major CSA
(ATM) Axis Imml Axislmm) (mm21
3.0mm LP 24 ± 0.20 2.67 ± 0.31 523 ± 130
In = 51 HP 2.77±0.11 2.97 ± 015 6.97 ± 0.42
3.5mm LP 2.6 ± 0.33' 2.75 ± 0.25' 6.65 ± 1.62'
In ~ 9) HP 2.9±017 32 ± 0.14 8.40 ± 0.76
4.0mm LP 30 ± 0.23' 3.3 ± 0.37' 8.34 ± 1.9'
In = 51 HP 36 ± 0.20 3.8 ± 025 11.44± 1.6
, P " 0.05 by paired t test LP vs HP
There were no statistically significant angiographic differences before and
after high pressure dilatations in all 3 stent size groups.
Conclusions: 1) The less than expected luminal diameter and cross sec-
tional area following stent deployment at low pressures can be significantly
improved by post deployment high pressure dilatation(s} with a non compli-
OCA ICUS % DE ICUS % AE Asymmetry
MC(n = 19) 8.2 ± 9.9 83 ± 92 78 ± 12 079 ± 10
HC In = 13) 9.5 ± 10.4 63 ± 11.7 69 ± 9 065 ± 009
significance p ~ NS p < 0.001 p = 003 p < 0001
Lesion Composition Impacts Size and Symmetry
of Stent Expansion: Initial Report from the STRUT
Registry
Peter J. Fitzgerald, Strut Registry Investigators. Stanford University, Stanford, CA
The STRUT (Stent Treatment Region assessed by Ultrasound Tomography)
Registry is a multicenter study using intracoronary ultrasound (ICUSj to ex-
amine stents (STs) implanted with high pressure. Analysis of the first 32 STs
in 29 patients has revealed a previously unreported relationship between the
extent and symmetry of ST expansion, and the presence of localized calcium
deposits in the lesion. STs were deployed with a mean pressure of 14.2 ATMs
resulting in an overall residual angiographic stenosis of 8.6 ± 12%. At the
end of the procedure a slow ICUS pullback (0.5-1 .0 mm/sec) was performed
through the ST segment. ICUS cross-sectional images were analyzed at 2.5
mm increments throughout the ST and proximal and distal reference seg-
ments. Cross-sections within the ST were characterized by ICUS as either
heavily calcified (HC: arc> 180" extending >5 mm) or non/mildly calcified
(MC: arc 0-180", ::::5 mm). STexpansion was analyzed in terms of: OCA %
stenosis; ICUS % diameter expansion (DE = minimum diameter in ST I nom-
inal ST diameter x 100); ICUS % area expansion (AE = minimum area in ST
I final balloon area x 100); and asymmetry (maximum divided by minimum
diameter within STl.
Incomplete ST apposition to vessel wall occurred in 7/14 (50%) of HC seg-
ments compared to 2/18 (11%) MC lesions. In MC and HC, the balloon to
vessel ratio was similar (0.72 ± 0.13 vs. 0.74 ± 0.16, P = NS).
In conclusion, target lesion calcification influences the overall expansion,
apposition and shape of ST deployment. Potential clinical impact will be as-
sessed by clinical and angio follow-up at 6 months.
The Impact of Intravascular Ultrasound (IVUS) on
Post·Stent Deployment Balloon Dilatation
Strategies
Jeffrey J. Popma, Antonio Colombo, Gary S. Mintz, S. Chiu Wong, Augusto
D. Pichard, Kenneth M. Kent. Lowell F. Satler, Donald S. Baim, Ya Chien Chuang,
Elizabeth Kennard, Theresa A. Bucher, Robert A. DeFalco, S. Shareghi, Martin
B. Leon. Washington Hospital Center, Washington, DC
less recoil, or both. 3) In the PTCA group, vessel expansion accounts for
only 20% of the acute gain, while plaque compression appears to be the
predominant mechanism of luminal enlargement.
To evaluate the impact of IVUS on post-stent deployment balloon dilatation
strategies, we compared the quantitative angiographic results in 1044 le-
sions undergoing native vessel (N = 415) or saphenous vein graft (SVG) (N
= 629) stent implantation using a tubular slotted (JJIS) stent design. Compar-
ison groups include the New Approaches to Coronary Intervention Registry
(NACI, 1990-93), Washington Hospital Center (WHCj Stent Registry (native
vessel, 1990-1992; SVG, 1992-94) and 2 IVUS-guided (complete stent ap-
position, symmetry, and expansion) stent deployment protocols (Colombo
in native vessels, 1993; Reduced Anticoagulation After Vein Graft Stent
[RAVES] Study, 1993-4). Cineangiograms were analyzed at a central Core
Laboratory using identical angiographic methodology (ImageComm). Bal-
loon:artery ratios (BAR) were measured using the mean balloon diameter.
Native Vessels SVGs
NACI WHC Colombo NACI WHC RAVES
Number Lesions 154 140 121 152 443 34
Reference, mm 3.26 326 309 3.47 3.68 351
% Adjunct Balloon 46 74 100 61 58 100
Balloon: Artery Ratio 1.10 1.08 1.28 1.09 1,12 1.23
MLD-Pre, mm 0.90 0.90 1.02 1.03 1.25 1.27
Post-Stent, mm 2.74 2.58 2.80 2.88 3.03
Final, mm 290 290 317 3.07 3.41 353
1:> MLD alter balloon' 038 026 045 0.44 073
% Stenosis - Pre 72 73 67 70 66 64
Post-Stent 16 22 20 20 14
Final 12 12 -2 14 7 -7
MLD = minimal lumen diameter
We conclude that 1) use of adjunct PTCA after stent deployment has in-
creased, based on incomplete stent deployment identified by IVUS (despite
an acceptable angiographic result); 2) BARs were higher after IVUS-guided
stent deployment; and 3) IVUS-guided stent deployment result in a very low
1-2% in native arteries, -7% in SVGs) final % stenosis, Assessment of the
